Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program
Expanding initiative focused on next generation sequencing services helps to advance genomics research On the heels of Integrated DNA Technologies' xGen NGS portfolio launch in December, MLL, the
Source: finanznachrichten.de